The role of Nrf2 in acute and chronic muscle injury
Open Access
- 8 December 2020
- journal article
- research article
- Published by Springer Nature in Skeletal Muscle
- Vol. 10 (1) , 1-22
Abstract
The nuclear factor erythroid 2-related factor 2 (Nrf2) is considered as a master cytoprotective factor regulating the expression of genes encoding anti-oxidant, anti-inflammatory, and detoxifying proteins. The role of Nrf2 in the pathophysiology of skeletal muscles has been evaluated in different experimental models, however, due to inconsistent data, we aimed to investigate how Nrf2 transcriptional deficiency (Nrf2tKO) affects muscle functions both in an acute and chronic injury. The acute muscle damage was induced in mice of two genotypes—WT and Nrf2tKOmice by cardiotoxin (CTX) injection. To investigate the role of Nrf2 in chronic muscle pathology,mdxmice that share genetic, biochemical, and histopathological features with Duchenne muscular dystrophy (DMD) were crossed with mice lacking transcriptionally active Nrf2 and double knockouts (mdx/Nrf2tKO) were generated. To worsen the dystrophic phenotype, the analysis of disease pathology was also performed in aggravated conditions, by applying a long-term treadmill test. We have observed slightly increased muscle damage in Nrf2tKOmice after CTX injection. Nevertheless, transcriptional ablation of Nrf2 inmdxmice did not significantly aggravate the most deleterious, pathological hallmarks of DMD related to degeneration, inflammation, fibrotic scar formation, angiogenesis, and the number and proliferation of satellite cells in non-exercised conditions. On the other hand, upon chronic exercises, the degeneration and inflammatory infiltration of the gastrocnemius muscle, but not the diaphragm, turned to be increased in Nrf2tKOmdxin comparison tomdxmice. In conclusion, the lack of transcriptionally active Nrf2 influences moderately muscle pathology in acute CTX-induced muscle injury and chronic DMD mouse model, without affecting muscle functionality. Hence, in general, we demonstrated that the deficiency of Nrf2 transcriptional activity has no profound impact on muscle pathology in various models of muscle injury.Keywords
All Related Versions
Funding Information
- Narodowe Centrum Nauki (2012/06/A/NZ1/00004, 2016/21/B/NZ1/00293, 2018/30/A/NZ3/00412)
- Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University (BMN 7/2017)
This publication has 70 references indexed in Scilit:
- Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stageDevelopment, 2012
- microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in miceJournal of Clinical Investigation, 2012
- Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular DystrophyThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Modification of Keap1 Cysteine Residues by SulforaphaneChemical Research in Toxicology, 2011
- Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic ApplicationsBioMed Research International, 2011
- Stress-Activated Cap'n'collar Transcription Factors in Aging and Human DiseaseScience Signaling, 2010
- Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-βJournal of Clinical Investigation, 2009
- The transcription factor NRF2 protects against pulmonary fibrosisThe FASEB Journal, 2004
- The muscular dystrophiesThe Lancet, 2002
- Helper (CD4+) and Cytotoxic (CD8+) T Cells Promote the Pathology of Dystrophin-Deficient MuscleClinical Immunology, 2001